Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production

Ling-Jun Ho, Jaang-Jiun Wang, Men-Fang Shaio, Chuan-Liang Kao, Deh-Ming Chang, Shou-Wha Han and Jenn-Haung Lai
J Immunol February 1, 2001, 166 (3) 1499-1506; DOI: https://doi.org/10.4049/jimmunol.166.3.1499
Ling-Jun Ho
*Rheumatology/Immunology and Allergy, Department of Medicine, Tri-Service General Hospital;
†Graduate Institute of Life Science;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaang-Jiun Wang
‡Institute of Biology and Anatomy; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Men-Fang Shaio
§Department of Parasitology and Tropical Medicine, National Defense Medical Center, Taiwan, Republic of China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chuan-Liang Kao
¶School of Medical Technology, College of Medicine and Division of Infectious Disease, National Taiwan University, Taiwan, Republic of China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deh-Ming Chang
*Rheumatology/Immunology and Allergy, Department of Medicine, Tri-Service General Hospital;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shou-Wha Han
∥Immunology Division, Cheng-Hsin Rehabilitation Medical Center, Taiwan, Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenn-Haung Lai
*Rheumatology/Immunology and Allergy, Department of Medicine, Tri-Service General Hospital;
†Graduate Institute of Life Science;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Dengue virus (DV) infection is a major problem in public health. It can cause fatal diseases such as Dengue hemorrhagic fever and Dengue shock syndrome. Dendritic cells (DC) are professional APCs required for establishing a primary immune response. Here, we investigated the role of human PBMC-derived DC in DV infection. Using different techniques, including plaque assay, flow cytometry analysis, nested RT-PCR, and confocal microscope and electron microscope examinations, we show that DV can enter cultured human DC and produce virus particles. After entrance, DV could be visualized in cystic vesicles, vacuoles, and the endoplasmic reticulum. The DV-infected DC also showed proliferation and hypertrophy of the endoplasmic reticulum as well as the swollen mitochondria. In addition, the DV-stimulated DC could express maturation markers such as B7-1, B7-2, HLA-DR, CD11b, and CD83. Furthermore, the infection of DC by DV induced production of TNF-α and IFN-α, but not IL-6 and IL-12. Although DC underwent spontaneous apoptosis in the absence of feeding cytokines, this process appeared to be delayed after DV infection. Our observations provide important information in understanding the pathogenesis of DV infection.

Dengue viruses (DV)3 are arthropod-borne flaviviruses that cause serious human diseases all over the world, especially in Asia. There are four serotypes of DV (DV1, -2, -3, and -4), and infection by each of them may result in either a relatively benign febrile course called Dengue fever (DF) or fatal outcomes, such as Dengue hemorrhagic fever (DHF) and Dengue shock syndrome (DSS). In 1998 DF was the most important tropical infectious disease after malaria. It is estimated that DV infection results in 100 million cases of DF, 500,000 cases of DHF, and 25,000 deaths annually (1). Nevertheless, although there are many proposed mechanisms, the pathogenesis of DHF and DSS is still far from understood (2, 3).

After DV infection most patients are viremic in the early febrile phase, and the viruses are quickly cleared from the blood after defervescence (4). The activation of both humeral and cellular immune responses is considered to be involved in virus clearance; the former response is shown by detecting the increased serum neutralizing Ab levels, and the latter is correlated with the generation and activation of CD4+ and CD8+ T lymphocytes that recognize serotype-specific, Dengue serotype cross-reactive epitopes (4, 5, 6, 7). The activation of T lymphocytes and other immune effector cells then leads to increased levels of TNF-α, soluble TNF receptor (sTNFR/75), IL-8, IFN-γ, and other mediators that may be associated with the pathogenesis of increased vascular permeability, a characteristic picture seen in DHF/DSS patients (8, 9, 10, 11). Importantly, not only the activation of CD8+ T lymphocytes but also the level of cytokines and the production of viruses, compared with those in DF patients, are significantly higher in DHF patients (7, 11, 12). Because both virus replication in organs such as brain, skin, and lymph nodes and host factors such as cytokines influence the pathogenesis of DV infection in humans, the identification of the natural hosts for DV as well as the subsequent consequences of the infected cells and their interactions with T lymphocytes appear to be critical for effective therapy of DV infection.

Dendritic cells (DC) are potent APCs that, after infection, migrate from peripheral tissues to the lymph nodes and activate CD4+ and CD8+ T lymphocytes (13, 14, 15, 16). By using mutational analysis, this migration step has been shown to be crucial for viral pathogenesis (17). The T lymphocyte stimulatory capacity is mediated through both the increased expression of B7-1 and B7-2 costimulatory molecules and the secretion of a variety of cytokines (16, 18). Reciprocally, DC may be activated or regulated by environmental factors, chemokines as well as cytokines (reviewed in Refs. 19, 20, 21). Furthermore, DC can efficiently help maintain the protective antiviral cytotoxic T cell memory (22). Because DC have been shown to bind and allow replications of many viruses (23, 24, 25, 26 ; reviewed in Refs. 27 and 28), we postulated that DC could be infected with DV and possibly play a role in the pathogenesis of DV infection through an increase in virus load and cell activation.

In the present study we show that DV could efficiently infect DC and produce virus particles. After infection, DC were activated to secrete TNF-α and IFN-α and were driven to undergo the maturation process. Given that DC underwent spontaneous apoptosis in the absence of feeding cytokines and that the infection of DC by DV resulted in accelerated cell apoptosis in the early phase after infection, both cell maturation and cytokine production could probably produce an anti-apoptotic effect in the late phase of infection.

Materials and Methods

Culture medium and reagents

The cell culture medium consisted of RPMI 1640 (Life Technologies, Gaithersburg, MD) supplemented with 10% FBS, 2 mM glutamine, and 1000 U/ml penicillin-streptomycin (Life Technologies, Gaithersburg, MD). Recombinant GM-CSF and IL-4 were purchased from R&D Systems (Minneapolis, MN). mAb to viral E protein was obtained from supernatants of hybridoma cells (HB46; American Type Culture Collection, Manassas, VA) and mAb to viral nonstructural protein 1 (NS1) with high specificity has been described previously (29). The fluorescence-labeled mAbs against cell surface molecules were purchased as follows: anti-B7-1, anti-HLA-DR, anti-CD3, anti-CD19, anti-CD14, and anti-CD56 from Becton Dickinson (Mountain View, CA); anti-B7-2 and anti-CD83 from PharMingen (San Diego, CA); and anti-CD11b from Dako (Carpinteria, CA). The isotype-matched control mAb for flow cytometric analysis was purchased from either PharMingen or Becton Dickinson. Unless otherwise indicated, the rest of the reagents were purchased from Sigma (St. Louis, MO).

Establishment of DC from human PBMC

The generation of DC from human PBMC was performed as described by Romani et al. (30). In brief, whole blood (20–50 ml) from healthy donors (>80 participants) was mixed with Ficoll-Hypaque, and after centrifugation the layer of mononuclear cells was collected. After lysis of RBC, the mononuclear cells were laid on petri dishes (Costar, Cambridge, MA) for 30–60 min at 37°C to remove nonadherent cells. After five washes with PBS, adherent cells were cultured in 3 ml of medium containing 800 U/ml GM-CSF and 500 U/ml IL-4. The culture medium was changed every other day with 300 μl of fresh medium containing 2400 U of GM-CSF and 1500 U of IL-4. The detached cells, the main population of CD1a+ cells (our unpublished observations), were used for experiments after culture for 7–10 days. During this period of time, the examination of cell type-specific markers in a gated population of established DC showed CD14 (0%), CD3 (0%), CD19 (1%), and CD56 (2%). Consistently, >95% of the cells in the gated region expressed CD1a.

Preparation of DV

The preparation of DV has been described previously (31). In brief, four serotypes of DV were propagated in C6/36 mosquito cells in half DMEM and half Mitsuhashi and Moramorosch insect medium containing 2% heat-inactivated FCS at 28°C for 7 days. The supernatants were collected and stored at −70°C until use. The virus titer was determined to be 4 × 106 to 3 × 107 PFU/ml by plaquing on baby hamster kidney (BHK) cells. The strains of four serotypes of DV used in this study were described previously or obtained as follows: DV1, Hawaii strain (American Type Culture Collection); DV2, New Guinea C strain (32); DV3, H87 strain (American Type Culture Collection); and DV4, H241 strain (American Type Culture Collection). Unless otherwise specified, DV2 New Guinea C strain was used as the source of DV to infect DC throughout this paper.

Infection of DC with DV

DC cultured for 7–10 days were infected with mock (C6/36 mosquito cell culture supernatants) or different DV serotypes at various multiplicities of infection (MOIs) for 4 h at 37°C as modified from the report by Hung et al. (31). Cells were then washed and cultured in six-well plates (Costar) with culture medium supplemented with or without cytokines as indicated in the figure legends. Cell density was maintained at 1 × 106/ml in 0.5–2 ml of the medium.

Measurement of virus titers

The supernatants from DV-infected DC were collected at various time points as indicated. The production of virus particles in supernatants was determined by titration on adherent BHK cells, permissive to four serotypes of DV. The numbers of plaques were counted and shown as PFU per milliliter. Virus titers <102 were taken as 102 for convenience.

Confocal microscope and electron microscope examinations

After infection, DC were collected at 24 and 48 h and fixed in 4% paraformaldehyde in 0.1 M PBS, pH 7.4, for 30 min. The DC cell suspensions were adhered to a polylysine-coated slide, permeabilized by incubating with 1% Triton X-100 for 5 min twice, and stained with anti-NS1 mAb (29), and then rabbit anti-mouse Ab conjugated with FITC (Jackson ImmunoResearch Laboratories, West Grove, PA) was added. After washing, the cells were stained with goat anti-CD1a polyclonal Ab (Santa Cruz Biotechnology, Santa Cruz, CA), followed by biotin-conjugated anti-sheep/goat mAb (Amersham Pharmacia, Piscataway, NJ), which was finally labeled with streptavidin-Cy3 (Amersham Pharmacia). For electron microscopy, DC cell pellets were collected and fixed in 2.5% glutaraldehyde and 0.1 M cacodylate buffer. After dehydrations with ethanol, the cells were embedded in eponate-12 as described previously (33), and examined under a transmission electron microscope (JEM 1230; JEOL, Peabody, MA).

Determination of cytokine production and cell surface molecule expression

Standard ELISAs were used to measure cytokine concentrations in harvested supernatants as detailed in our previous work (34). All determinants were performed in duplicate (IL-6 and IFN-α) or triplicate (TNF-α and IL-12) and expressed as the mean ± SD. The detection limits for these cytokines are: TNF-α, 5 pg/ml (R&D Systems); IFN-α, 10 pg/ml (Endogen, Woburn, MA); IL-6, 3 pg/ml (R&D Systems); and IL-12, 7 pg/ml (R&D Systems). The expression of cell surface molecules was determined by flow cytometric analysis (35). Each histogram or density plot comprised at least 104 events.

Measurement of cellular apoptosis by flow cytometric analysis

The mock-treated or DV-infected DC, after washing with cold PBS, were pelleted and resuspended in binding buffer containing HEPES-buffered PBS supplemented with 2.5 mmol/l CaCl2. Then 10 μl of annexin V-FITC at a concentration of 10 μg/ml and 10 μl of propidium iodide (PI) at a concentration of 50 μg/ml were added to each sample and incubated for 15 min at room temperature. After washing, the cells were analyzed by a flow cytometer (Becton Dickinson). The annexin V+ and PI− population represents early apoptosis, and the late apoptotic or necrotic population is shown to be annexin V+ and PI+.

Nested RT-PCR

To determine the specificity of DV2, a nested RT/PCR method described by Lanciotti et al. (36) was exactly adapted. In brief, the viral RNA was isolated from the supernatants of DV-infected DC. After RT of RNA to cDNA, samples were subjected to PCR. The consensus primers 5′-TCAATATGCTGAAACGCGCGAGAAACCG-3′ (D1 primer, genomic positions 134–161) and 5′-TTGCACCAACAGTCAATGTCTTCAGGTTC-3′ (D2 primer, genomic positions 616–644) were used to amplify 511-bp DNA products (our unpublished observations). After the first-round amplification reaction with consensus primers, a second-round amplification reaction was conducted, except that the D2 primer was replaced with the DV2-specific primer 5′-CGCCACAAGGGCCATGAACAG-3′ (genomic positions 232–252). The RT-PCR working conditions have been detailed previously (36). The final products were analyzed on a 4% agarose gel, stained with ethidium bromide, and visualized under UV light. After the second-round PCR, a 119-bp product specific for DV2 is detected.

Statistics

When necessary, the results were expressed as the mean ± SD. A paired (for comparison of cytokine production) or unpaired (for comparison of virus titers) Student’s t test was used to determine the difference, which was considered significant at p < 0.05.

Results

Establishment of DC from human PBMC

DC were propagated from culturing adherent human PBMC in the presence of GM-CSF and IL-4. The detached cells were then removed at different time points, stained with anti-CD1a or isotype-matched control mAb, and analyzed in a flow cytometer. As shown in Fig. 1⇓A, after culture for >7 days, >95% of the gated monocyte-derived DC population expressed CD1a. In contrast, the expression of CD14 was barely detectable after 7 days of culture (Fig. 1⇓B). All of the following experiments were performed using DC cultured for 7–10 days. At this time point, DC routinely represented 65–95% of the total cell population. Such an estimation is a conservative, low measure of the DC population, because a significant number of unstained “cells” are acellular debris, as characterized by their size and light scatter properties in flow cytometric analysis.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Generation and identification of DC from human peripheral blood. A, Whole blood was obtained from healthy donors. After mixing with Ficoll-Hypaque and centrifugation, the layer containing mononuclear cells was collected. The adherent mononuclear cells were cultured and maintained in complete medium containing IL-4 and GM-CSF. After culturing for 3, 5, 7, and 10 days, the detached cells were stained with CD1a or isotype-matched control mAb. B, The first-day cells (collected from scratching the attached cells with a policeman) and the seventh-day cells (detached) were stained with both CD14 and CD1a or isotype-matched control mAb. The gated areas represent the monocyte-derived DC populations. Each density plot or histogram is generated using at least 104 events.

Infection of DC by DV

Because DC were established in the culture medium containing IL-4 and GM-CSF, we first investigated the effects of these cytokines on virus production. After infection with DV2 New Guinea C strain at an MOI of 1, DC were maintained in the culture medium with or without cytokines. As shown in Fig. 2⇓A, DC could provide efficient replications of DV and yielded infectious virus particles in both conditions. In the presence of cytokines, higher titers of virus particles were produced. To minimize the effects of cytokines, the rest of the experiments were conducted without supplementing the culture medium with cytokines after DV infection. The specificity of the productive infection of DV2 was subsequently confirmed with nested RT-PCR that detects a 119-bp product specific for DV2 in the culture supernatants (Fig. 2⇓B). These results exclude the possibility that the productive infection of DC by DV2 is because of the contamination by other DV serotypes or other flaviviruses. The infection of DC by DV was further investigated by staining both the intracellular viral NS1 protein and the cell surface CD1a molecule and then was analyzed under a confocal microscope. As illustrated in Fig. 2⇓C, only DV-infected, but not mock-treated, DC coexpressed CD1a and NS1 proteins. As predicted, CD1a was localized on the cell surface, whereas NS1 was located in the cytosol (Fig. 2⇓C, lower panel, showing better contrast). In our preliminary studies we also found that neither purified B lymphocytes nor T lymphocytes, two major populations contaminating DC purity, could be infected by DV (our unpublished observations). Therefore, these results strongly suggest that DV could infect cultured human DC.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

DV infect DC. A, After mock treatment or DV2 New Guinea C strain infection at an MOI of 1, DC were seeded back onto dishes and maintained in the culture medium with or without adding IL-4 and GM-CSF. The supernatants were collected every day for 5 days, and the virus titers were measured by standard plaque assays. Each point represents the mean ± SD for two determinants in duplicate or triplicate. B, After infection of DC with DV at an MOI of 1 in the absence of supplemented cytokines, the supernatants were harvested at the indicated time points and analyzed with nested RT-PCR as described in Materials and Methods. Bands shown are 119-bp PCR products specific for DV2. MK, 100-bp DNA ladders. C, After mock treatment or DV infection at an MOI of 10, DC were collected 48 h later and stained for intracellular NS1 and cell surface CD1a molecules, then visualized under a confocal microscope.

Localization of DV particles

To investigate the organelle of DC where DV resided, the infected DC were examined under an electron microscope. As shown in Fig. 3⇓a, after infection for 24 h DV particles were obvious in cystic vesicles, vacuoles, and the endoplasmic reticulum. Fig. 3⇓B clearly shows the structures of the rough endoplasmic reticulum with virus particles inside. This is consistent with the characters of flavivirus infection (37). In addition, virus-induced hypertrophy and proliferation of the rough endoplasmic reticulum as well as swollen mitochondria were observed (Fig. 3⇓, a and b). We could not find similar pictures in mock-treated DC (our unpublished observations). These findings may suggest a cell undergoing apoptosis, although in this particular picture of EM, the nuclear condensation has not developed yet (38) (Fig. 3⇓a). However, we did observe many DV-infected cells showing pictures of nuclear condensation (our unpublished observation). Because mock-treated DC also showed patterns of nuclear condensation, whether these findings in DV-infected DC were due to DV infection or as were the result of a spontaneous consequence in the absence of feeding cytokines was not clear. When the cells were examined 48 h after infection, bulky virus particles inside the vesicle were detected, and virus release out of the cell membrane became evident (Fig. 3⇓c).

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Localization of DV in DC. After infection with DV at an MOI of 10 for 24 h (a and b) or an MOI of 20 for 48 h (c), DC were collected and visualized under an electron microscope as described in Materials and Methods. Bars: a, 0.5 μm; b, 0.5 μm; c, 0.3 μm. N, Nucleus; m, mitochondria; rer, rough endoplasmic reticulum; arrowheads, virus particles.

Infection of DC by different DV serotypes

There are four serotypes of DV (DV1–4), and their infectivities in DC were examined. As shown in Fig. 4⇓, although the production of virus titers was different, four serotypes of DV at an MOI of 1 could infect DC.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Productive infection of four DV serotypes in DC. After infection of DV1–4 at an MOI of 1, DC were seeded back into the culture medium, the supernatants were collected every day for 5 days, and the titers of virus particles were determined in BHK cells. The results are representative of three individual experiments performed in duplicate.

Maturation of DC after DV infection

After confirming the infection of DC by DV, the possible outcomes of DC after infection were investigated. There are two stages in DC development. In the immature stage, DC primarily phagocytose and process Ag, whereas in the mature stage, DC function as the best Ag presenters to T lymphocytes by up-regulating the expression of costimulatory and HLA-DR molecules (16). We determined whether DV infection of DC could enhance the expression of these cell surface molecules. After mock infection or infection with DV at an MOI of 1 for 48 h, cells were collected, and the gated DC population was analyzed for cell surface molecule expression. As shown in Fig. 5⇓, compared with mock-treated DC, DV infection induced significant expression of B7-1, B7-2, CD11b, HLA-DR, and CD83 on DC. Thus, DV infection of DC induced cellular maturation.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Expression of cell surface molecules on DV-infected DC. After mock treatment or DV infection at an MOI of 1 for 48 h, DC were collected, and the expression of several cell surface markers was measured with a flow cytometer. Data shown are representative of at least five individual experiments. Dashed lines represent staining of isotype-matched control mAb, thin lines (filled areas) represent staining of mock-treated DC markers, and thick lines represent staining of DV-infected DC markers. M, Mock-treated; D, DV-infected.

Differential regulation of cytokine production from DV-infected DC

Aside from the expression of costimulatory molecules, DC also initiate a potent immune response through the secreted cytokines. The supernatants from mock-treated or DV-infected DC were collected at 48 h after infection and assayed for several cytokine concentrations. As shown in Fig. 6⇓A, the cultured DC spontaneously produced a variety of cytokines, consistent with other reports (39, 40). In the presence of DV infection, DC produced higher levels of IFN-α and TNF-α, but not IL-12 and IL-6. The production of IFN-γ was not detectable (our unpublished observations). The induction of TNF-α production could also be observed in four serotypes of DV infection (Fig. 6⇓B).

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Cytokine production in DV-infected DC. A, The supernatants harvested 48 h after mock treatment or DV infection at an MOI of 1 of DC were analyzed with ELISAs to measure the concentrations of cytokines as described. After obtaining the mean values of the duplicate (IL-6 and IFN-α) or triplicate (IL-12 and TNF-α) measurements of cytokines in each donor DC, the results were readily compared between mock-treated and DV-infected samples by paired t test. M, Mock-treated; D, DV-infected; n, number of individual donor DC. B, The supernatants from DV1–4-infected DC were collected every 24 h and assayed for TNF-α secretions. The data are representative of three individual experiments.

Anti-apoptotic effect of cell maturation and cytokine production in DV-infected DC

In the absence of feeding cytokines, DC died through an apoptotic pathway, similar to that observed in spontaneous apoptosis of monocytes (41) (our unpublished observations). We found that compared with mock treatment, DV infection resulted in a higher percentage of cell death in the early phase of infection (see below). Such an accelerated apoptotic mechanism appeared not to involve Fas/Fas ligand interaction, because these two molecules were not induced on DV-infected DC (our unpublished observations). It has been shown that mature DC are more resistant than immature DC to vaccinia virus-induced cell apoptosis; we determined whether this could also be observed in DV infection (26, 42). Both mock-treated and DV-infected DC cultured for longer periods of time in the absence of exogenous cytokines were stained with annexin V-FITC and PI and examined with a flow cytometer. As shown in Fig. 7⇓, compared with mock-treated DC, DV infection induced more DC showing annexin V+PI− and annexin V+PI+ in the first 22 h. In contrast to mock-treated DC that died rapidly after 22 h, the DV-infected DC were more resistant to apoptosis.

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

Anti-apoptotic effect of DV-infected DC. DC were treated with mock or DV at an MOI of 1 for 4 h, and after extensive washes the cells were seeded back into the culture medium without adding IL-4 or GM-CSF. The cells were then collected at different time points and stained with annexin V-FITC and PI, and the fluorescence intensity was determined with a flow cytometer. Data shown are representative of four individual experiments.

Discussion

It remains elusive which tissue cells are the natural targets in which DV reside and which produce virus particles. Both immune effector cells such as monocytes and T lymphocytes and nonimmune cells such as hepatocytes, endothelial cells, and brain cells were reported to be potential hosts (9, 43, 44). However, none of these cells could efficiently present virus Ags to T lymphocytes. Although human Kupffer cells, effective APCs, can be infected by DV, no viral progeny synthesis is detected (45).

Human PBMC cultured with recombinant IL-4 and GM-CSF were shown to generate DC with the most efficient Ag-presenting function (46). In the presence of DC maturation factor CD40 ligand, these myeloid lineage DC become potent inducers of Th1 differentiation (47). Using different techniques, we show that DC, established from this well-appreciated condition, could provide DV to enter and produce virus particles. In addition, this conclusion was consistently observed in four different serotypes of DV infection (Fig. 4⇑). In our hands, both purified human T and B lymphocytes were poorly infected by DV (unpublished observations). According to Rosen et al. (48), 7 of 16 mesenteric lymph node specimens and 13 of 18 spleen specimens from children dying of DHF contain DV RNA. It is highly possible that DC may be one of the primary targets of DV in these infected tissues. In support of this idea as well as our observations, while this paper was under review Wu et al. (49) provided convincing evidence that DV could infect DC both in vitro and in vivo.

By using different approaches, many known or sequence-unidentified molecules were reported to be potential DV receptors (50, 51, 52). Among previous reports, Chen et al. (53), using Vero cells as target cells, presented convincing evidence showing that the highly sulfated glycosaminoglycan (GAG) is the putative cellular receptor for DV. Interestingly, we found that among the GAGs examined, heparin, heparan sulfate, and dermatan sulfate, but not chondroitin sulfate A, could inhibit DV-DC binding (unpublished observations). Examination of the molecular mass (kilodaltons) and the number of sulfate groups per disaccharide unit (SO3−/COO− ratio) of these compounds shows the order of molecular mass as chondroitin sulfate A (30 kDa)>dermatan sulfate (28 kDa)>heparan sulfate (18 kDa)>heparin (13.6 kDa), and the order of SO3−/COO− ratio as heparin (2.14)>dermatan sulfate (1.22)>chondroitin sulfate A (1)>heparan sulfate (0.93) (54). Thus, although the sulfation of GAGs is important for virus-DC binding in several examples (53, 54, 55, 56, 57), our preliminary observations suggest that, in contrast to Vero cells, the binding of DV to DC may have no strong correlation with the levels of sulfation of GAGs.

DC undergo the maturation process and migrate from peripheral tissues to lymph nodes after being directly infected or phagocytosing apoptotic infected cells (58, 59). The DC maturation process can be regulated by a variety of stimuli such as cytokines, viral products, and CD40 ligand. In the context of infection, micro-organisms use the mechanism of modulating the DC maturation process to influence the immune response. For example, the infection of DC by vaccinia virus inhibits DC maturation and therefore down-regulates its stimulatory capacity to T lymphocytes (42). A similar mechanism was demonstrated in herpes simplex virus infection (60). The infection of erythrocytes by Plasmodium falciparum induces the expression of PfEMP-1 Ag, which, after binding to DC, inhibits maturation of immature DC (61). The infection of DC by Trypanosoma cruzi also results in inhibition of the maturation process (62); through the suppression of DC maturation, it may help virus to evade the immune regulation and to minimize the immune response. Although some micro-organism infections may impair the maturation process of DC, other pathogens could drive DC maturation after infection. As reported by Schnorr et al. (63), measles virus infection of DC induces DC maturation that, in turn, causes immunosuppression through as yet unidentified mechanisms. The induction of DC maturation may also result in protection against a viral cytopathic effect and help stabilize the production of viral progeny (26). Similar effects were indeed observed in the example of DV infection of human DC shown in this report (Fig. 7⇑).

In reaction to the entrance of virus, DC may release various cytokines to initiate an immune response and probably leading to the pathological changes seen in virus infection (59). The production of cytokines from DV-infected DC seem to be differentially regulated; only TNF-α and IFN-α, not IL-6 and IL-12, were significantly induced (Fig. 6⇑A). The induction of TNF-α in DV-infected DC was correlated very well with clinical observations examining TNF-α levels in plasma samples from DV-infected patients (11, 64). Importantly, the increase in TNF-α was more often detected in DHF patients’ plasma than in that from DF patients or non-Dengue febrile illness patients (11). Because the secretion of cytokines may be regulated in different kinetics, we do not exclude the possibility that both IL-6 and IL-12 may be maximally induced at later time points after infection. Regarding the cytokines secreted from DV-infected DC, the type 1 IFN has been shown to mediate the antiviral response (65, 66, 67). In the example of dsRNA infection of DC, the anti-apoptotic mechanism of IFN-α is associated with the induction of MxA protein that exerts anti-cytopathic effects (26, 68). Similarly, TNF-α can protect DC from cell death through up-regulating anti-apoptotic factors such as Bcl-xl (69, 70). Thus, aside from cell maturation, the virus-induced production of TNF-α and IFN-α may also contribute to the lesser cell death in DV-infected DC in the late phase of virus infection (Fig. 7⇑).

Whether DV infection results in DC apoptosis is still an open question. In our system because DC were infected with DV in the absence of feeding cytokines, it has been very difficult to differentiate DV-induced apoptosis from cytokine withdrawal-induced apoptosis. Our preliminary results also suggest that DV infection could not induce the expression of Fas/Fas ligand on DC (our unpublished observations). The addition of both IL-4 and GM-CSF growth factors to the culture could rescue DV-infected DC from undergoing apoptosis (our unpublished observations). Apparently, more sophisticated experiments are required to resolve this issue.

In conclusion, in this study we provide evidence that human DC support the active replication of DV. After infection by DV, DC secrete cytokines that probably lead to cell maturation. Through the infection and activation of DC, it may induce the activation of T lymphocytes and initiate an adaptive immune response. Although DV infection might accelerate the apoptotic process in cytokine-withdrawn DC, both cell maturation and cytokine production could delay or block the ongoing process of apoptosis.

Acknowledgments

We thank Chien-Ting Lin, Yu-Lin Hsu, Moon-Chung Wu, and Chia-Ho Kuo for excellent technical assistance.

Footnotes

  • ↵1 This work was supported by grants from National Health Research Institutes (NHRI-CN-CL8902T-1 to M.-F.S. and NHRI-GT-EX89B915C to J.-H.L.) and in part by grants from Department of Defense (DOD-89-11 to M.-F.S., and DOD-88-15 and DOD-89-13 to J.-H.L.), Taiwan, Republic of China.

  • ↵2 Address correspondence and reprint requests to Dr. Jenn-Haung Lai, Rheumatology/Immunology & Allergy, Tri-Service General Hospital, No. 325, Sec. 2, Cheng-Kung Road, Naihu 114, Taipei, Taiwan, Republic of China. E-mail address: haungben{at}tpts5.seed.net.tw

  • ↵3 Abbreviations used in this paper: DV, Dengue virus(es); DC, dendritic cells; PI, propidium iodide; NS1, nonstructural protein 1; DHF, Dengue hemorrhagic fever; DSS, Dengue shock syndrome; BHK, baby hamster kidney; MOI, multiplicity of infection; GAG, glycosaminoglycan.

  • Received May 30, 2000.
  • Accepted November 14, 2000.
  • Copyright © 2001 by The American Association of Immunologists

References

  1. ↵
    Gubler, D. J.. 1998. Dengue and Dengue hemorrhagic fever. Clin. Microbiol. Rev. 11: 480
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Rothman, A. L., F. A. Ennis. 1999. Immunopathogenesis of Dengue hemorrhagic fever. Virology 257: 1
    OpenUrlCrossRefPubMed
  3. ↵
    Watts, D. M., K. R. Porter, P. Putvatana, B. Vasquez, C. Calampa, C. G. Hayes, S. B. Halstead. 1999. Failure of secondary infection with American genotype Dengue 2 to cause Dengue haemorrhagic fever. Lancet 354: 1431
    OpenUrlCrossRefPubMed
  4. ↵
    Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, A. L. Rothman, F. A. Ennis, A. Nisalak. 1997. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176: 322
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Mathew, A., I. Kurane, S. Green, H. A. Stephens, D. W. Vaughn, S. Kalayanarooj, S. Suntayakorn, D. Chandanayingyong, F. A. Ennis, A. L. Rothman. 1998. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary Dengue virus infection. J. Virol. 72: 3999
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Kurane, I., L. Zeng, M. A. Brinton, F. A. Ennis. 1998. Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for Dengue virus types 2, 3, and 4. Virology 240: 169
    OpenUrlCrossRefPubMed
  7. ↵
    Green, S., S. Pichyangkul, D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, A. Nisalak, I. Kurane, A. L. Rothman, F. A. Ennis. 1999. Early CD69 expression on peripheral blood lymphocytes from children with Dengue hemorrhagic fever. J. Infect. Dis. 180: 1429
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, J. Janus, F. A. Ennis. 1991. Activation of T lymphocytes in Dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with Dengue. J. Clin. Invest. 88: 1473
    OpenUrlCrossRefPubMed
  9. ↵
    Avirutnan, P., P. Malasit, B. Seliger, S. Bhakdi, M. Husmann. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161: 6338
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Bethell, D. B., K. Flobbe, X. T. Cao, N. P. Day, T. P. Pham, W. A. Buurman, M. J. Cardosa, N. J. White, D. Kwiatkowski. 1998. Pathophysiologic and prognostic role of cytokines in Dengue hemorrhagic fever. J. Infect. Dis. 177: 778
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Green, S., D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, R. Lew, B. L. Innis, I. Kurane, A. L. Rothman, et al 1999. Early immune activation in acute Dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179: 755
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, et al 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181: 2
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Steinman, R. M., M. D. Witmer. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75: 5132
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Bhardwaj, N., A. Bender, N. Gonzalez, L. K. Bui, M. C. Garrett, R. M. Steinman. 1994. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94: 797
    OpenUrlCrossRefPubMed
  15. ↵
    Bender, A., L. K. Bui, M. A. Feldman, M. Larsson, N. Bhardwaj. 1995. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J. Exp. Med. 182: 1663
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Banchereau, J., R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245
    OpenUrlCrossRefPubMed
  17. ↵
    MacDonald, G. H., R. E. Johnston. 2000. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74: 914
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Lane, P. J., T. Brocker. 1999. Developmental regulation of dendritic cell function. Curr. Opin. Immunol. 11: 308
    OpenUrlCrossRefPubMed
  19. ↵
    Lynch, D. H.. 1998. Induction of dendritic cells (DC) by Flt3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo. Crit. Rev. Immunol. 18: 99
    OpenUrlCrossRefPubMed
  20. ↵
    Steinman, R. M., K. Inaba. 1999. Myeloid dendritic cells. J. Leukocyte Biol. 66: 205
    OpenUrlAbstract
  21. ↵
    Sozzani, S., P. Allavena, A. Vecchi, A. Mantovani. 1999. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukocyte Biol. 66: 1
    OpenUrlAbstract
  22. ↵
    Ludewig, B., S. Oehen, F. Barchiesi, R. A. Schwendener, H. Hengartner, R. M. Zinkernagel. 1999. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J. Immunol. 163: 1839
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Langhoff, E., E. F. Terwilliger, H. J. Bos, K. H. Kalland, M. C. Poznansky, O. M. Bacon, W. A. Haseltine. 1991. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc. Natl. Acad. Sci. USA 88: 7998
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Hahn, G., R. Jores, E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95: 3937
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Grosjean, I., C. Caux, C. Bella, I. Berger, F. Wild, J. Banchereau, D. Kaiserlian. 1997. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med. 186: 801
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Oldstone, M. B.. 1998. Viral persistence: mechanisms and consequences. Curr. Opin. Microbiol. 1: 436
    OpenUrlCrossRefPubMed
  28. ↵
    Klagge, I. M., S. Schneider-Schaulies. 1999. Virus interactions with dendritic cells. J. Gen. Virol. 80: 823
    OpenUrlPubMed
  29. ↵
    Lin, Y. L., C. L. Liao, L. K. Chen, C. T. Yeh, C. I. Liu, S. H. Ma, Y. Y. Huang, Y. L. Huang, C. L. Kao, C. C. King. 1998. Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72: 9729
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacker, G. Konwalinka, P. O. Fritish, R. Steinman, G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Hung, S. L., P. L. Lee, H. W. Chen, L. K. Chen, C. L. Kao, C. C. King. 1999. Analysis of the steps involved in Dengue virus entry into host cells. Virology 257: 156
    OpenUrlCrossRefPubMed
  32. ↵
    Chang, D. M., M. F. Shaio. 1994. Production of interleukin-1 (IL-1) and IL-1 inhibitor by human monocytes exposed to Dengue virus. J. Infect. Dis. 170: 811
    OpenUrlFREE Full Text
  33. ↵
    Wang, J. J., Y. Lu, L. Ratner. 1994. Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy. J. Gen. Virol. 75: 2607
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Lai, J. H., L. J. Ho, C. Y. Kwan, D. M. Chang, T. C. Lee. 1999. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology. Transplantation 68: 1383
    OpenUrlCrossRefPubMed
  35. ↵
    Ho, L. J., D. M. Chang, T. C. Lee, M. L. Chang, J. H. Lai. 1999. Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells. Eur. J. Pharmacol. 367: 389
    OpenUrlCrossRefPubMed
  36. ↵
    Lanciotti, R. S., C. H. Calisher, D. J. Gubler, G. J. Chang, A. V. Vorndam. 1992. Rapid detection and typing of Dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30: 545
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Chambers, T. J., C. S. Hahn, R. Galler, C. M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44: 649
    OpenUrlCrossRefPubMed
  38. ↵
    Despres, P., M. Flamand, P. E. Ceccaldi, V. Deubel. 1996. Human isolates of Dengue type 1 virus induce apoptosis in mouse neuroblastoma cells. J. Virol. 70: 4090
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Kelleher, P., A. Maroof, S. C. Knight. 1999. Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur. J. Immunol. 29: 2309
    OpenUrlCrossRefPubMed
  40. ↵
    Buelens, C., V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, F. Willems. 1997. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol. 27: 756
    OpenUrlCrossRefPubMed
  41. ↵
    Fahy, R. J., A. I. Doseff, M. D. Wewers. 1999. Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J. Immunol. 163: 1755
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Engelmayer, J., M. Larsson, M. Subklewe, A. Chahroudi, W. I. Cox, R. M. Steinman, N. Bhardwaj. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163: 6762
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Despres, P., M. P. Frenkiel, P. E. Ceccaldi, C. Duarte Dos Santos, V. Deubel. 1998. Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent Dengue viruses. J. Virol. 72: 823
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Marianneau, P., A. Cardona, L. Edelman, V. Deubel, P. Despres. 1997. Dengue virus replication in human hepatoma cells activates NF-κB which in turn induces apoptotic cell death. J. Virol. 71: 3244
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Marianneau, P., A. M. Steffan, C. Royer, M. T. Drouet, D. Jaeck, A. Kirn, V. Deubel. 1999. Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident. J. Virol. 73: 5201
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Sallusto, F., A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179: 1109
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183
    OpenUrlAbstract/FREE Full Text
  48. ↵
    Rosen, L., M. T. Drouet, V. Deubel. 1999. Detection of Dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am. J. Trop. Med. Hyg. 61: 720
    OpenUrlAbstract
  49. ↵
    Wu, S.-J. L., G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. Filgueira, M. A. Marovich, H. K. Wong, et al 2000. Human skin Langerhans cells are targets of Dengue virus infection. Nat. Med. 6: 816
    OpenUrlCrossRefPubMed
  50. ↵
    Chen, Y., T. Maguire, R. M. Marks. 1996. Demonstration of binding of Dengue virus envelope protein to target cells. J. Virol. 70: 8765
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Ramos-Castaneda, J., J. L. Imbert, B. L. Barron, C. Ramos. 1997. A 65-kDa trypsin-sensible membrane cell protein as a possible receptor for Dengue virus in cultured neuroblastoma cells. J. Neurovirol. 3: 435
    OpenUrlCrossRefPubMed
  52. ↵
    Salas-Benito, J. S., R. M. del Angel. 1997. Identification of two surface proteins from C6/36 cells that bind Dengue type 4 virus. J. Virol. 71: 7246
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Chen, Y., T. Maguire, R. E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3: 866
    OpenUrlCrossRefPubMed
  54. ↵
    Rusnati, M., D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. di Fagagna, M. Giacca, M. Presta. 1997. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J. Biol. Chem. 272: 11313
    OpenUrlAbstract/FREE Full Text
  55. ↵
    Joyce, J. G., J. S. Tung, C. T. Przysiecki, J. C. Cook, E. D. Lehman, J. A. Sands, K. U. Jansen, P. M. Keller. 1999. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 274: 5810
    OpenUrlAbstract/FREE Full Text
  56. ↵
    Gallagher, J. T., J. E. Turnbull, M. Lyon. 1992. Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme. Int. J. Biochem. 24: 553
    OpenUrlCrossRefPubMed
  57. ↵
    Fromm, J. R., R. E. Hileman, E. E. Caldwell, J. M. Weiler, R. J. Linhardt. 1997. Pattern and spacing of basic amino acids in heparin binding sites. Arch. Biochem. Biophys. 343: 92
    OpenUrlCrossRefPubMed
  58. ↵
    Albert, M. L., B. Sauter, N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86
    OpenUrlCrossRefPubMed
  59. ↵
    Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767
    OpenUrlCrossRefPubMed
  60. ↵
    Salio, M., M. Cella, M. Suter, A. Lanzavecchia. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29: 3245
    OpenUrlCrossRefPubMed
  61. ↵
    Urban, B. C., D. J. Ferguson, A. Pain, N. Willcox, M. Plebanski, J. M. Austyn, D. J. Roberts. 1999. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400: 73
    OpenUrlCrossRefPubMed
  62. ↵
    Van Overtvelt, L., N. Vanderheyde, V. Verhasselt, J. Ismaili, L. De Vos, M. Goldman, F. Willems, B. Vray. 1999. Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect. Immunity 67: 4033
    OpenUrlAbstract/FREE Full Text
  63. ↵
    Schnorr, J. J., S. Xanthakos, P. Keikavoussi, E. Kampgen, V. ter Meulen, S. Schneider-Schaulies. 1997. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. USA 94: 5326
    OpenUrlAbstract/FREE Full Text
  64. ↵
    Hober, D., A. S. Delannoy, S. Benyoucef, D. De Groote, P. Wattre. 1996. High levels of sTNFR p75 and TNFα in Dengue-infected patients. Microbiol. Immunol. 40: 569
    OpenUrlCrossRefPubMed
  65. ↵
    van den Broek, M. F., U. Muller, S. Huang, M. Aguet, R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both α/β and γ interferon receptors. J. Virol. 69: 4792
    OpenUrlAbstract/FREE Full Text
  66. ↵
    Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918
    OpenUrlAbstract/FREE Full Text
  67. ↵
    Diamond, M. S., T. G. Roberts, D. Edgil, B. Lu, J. Ernst, E. Harris. 2000. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol. 74: 4957
    OpenUrlAbstract/FREE Full Text
  68. ↵
    Pavlovic, J., H. A. Arzet, H. P. Hefti, M. Frese, D. Rost, B. Ernst, E. Kolb, P. Staeheli, O. Haller. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69: 4506
    OpenUrlAbstract/FREE Full Text
  69. ↵
    Yeh, W. C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, et al 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715
    OpenUrlCrossRefPubMed
  70. ↵
    Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H. L. Li, R. M. Steinman, Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186: 2075
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Immunology: 166 (3)
The Journal of Immunology
Vol. 166, Issue 3
1 Feb 2001
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production
Ling-Jun Ho, Jaang-Jiun Wang, Men-Fang Shaio, Chuan-Liang Kao, Deh-Ming Chang, Shou-Wha Han, Jenn-Haung Lai
The Journal of Immunology February 1, 2001, 166 (3) 1499-1506; DOI: 10.4049/jimmunol.166.3.1499

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production
Ling-Jun Ho, Jaang-Jiun Wang, Men-Fang Shaio, Chuan-Liang Kao, Deh-Ming Chang, Shou-Wha Han, Jenn-Haung Lai
The Journal of Immunology February 1, 2001, 166 (3) 1499-1506; DOI: 10.4049/jimmunol.166.3.1499
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606